Malinda Linn, DO
Family Medicine · Hendersonville, TNNPI 1487778635
Payments from drug & device makers
Across 73 payments — averaging $198.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optos, Inc.$10K
- Teva Pharmaceuticals USA, Inc.$4K
- Lilly USA, LLC$196
- Astellas Pharma US Inc$195
- AbbVie$129
- AstraZeneca$95
- plus $478 from 17 others
What the payments were for
- Consulting fees$2,76119%
- Speaking & faculty fees$9,57766%
- Travel & lodging$5564%
- Food & beverage$1,38010%
- Education$1951%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optos, Inc. | 1 | $9,577 |
| Teva Pharmaceuticals USA, Inc. | 13 | $3,799 |
| Lilly USA, LLC | 11 | $196 |
| Astellas Pharma US Inc | 2 | $195 |
| AbbVie(2 entities) | 8 | $129 |
| AstraZeneca | 7 | $95 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Exact Sciences | 3 | $49 |
| Amgen | 3 | $44 |
| Sumitomo Pharma America, Inc. | 3 | $39 |
| Bayer | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Pfizer | 2 | $30 |
| Johnson & Johnson | 2 | $30 |
| Novartis | 2 | $26 |
| Novo Nordisk | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Medtronic | 1 | $17 |
| Lundbeck LLC | 1 | $14 |
| Indivior Inc. | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AJOVY$3,716
How this compares
$14,468 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $63,078 |
| EliquisApixaban | 36 | $35,970 |
| KerendiaFinerenone | 24 | $29,162 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 525 | $23,247 |
| Bydureon BciseExenatide Microspheres | 17 | $19,256 |
| MounjaroTirzepatide | 14 | $14,234 |
| JardianceEmpagliflozin | 15 | $13,971 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $12,663 |
| JanuviaSitagliptin Phosphate | 19 | $10,674 |
| GemtesaVibegron | 11 | $5,104 |
| Atorvastatin Calcium | 318 | $3,447 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $3,322 |
| SynthroidLevothyroxine Sodium | 41 | $3,003 |
| Levothyroxine Sodium | 204 | $2,379 |
| Gabapentin | 74 | $2,252 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $20 | $63,07857 claims |
| PfizerEliquis | $30 | $35,97036 claims |
| BayerKerendia | $34 | $29,16224 claims |
| Lilly USA, LLCMounjaro | $196 | $14,23414 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $39 | $5,10411 claims |
| AbbVieSynthroid | $129 | $3,00341 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Hendersonville
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
- Marcus LeeTullahoma$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.